Strain-dependent airway hyperresponsiveness and a chromosome 7 locus of elevated lymphocyte numbers in cystic fibrosis transmembrane conductance regulator-deficient mice

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2297-2304

  Bazett, Mark ^a   Stefanov, Anguel N ^a   Paun, Alexandra ^a   Paradis, Josee ^a   Haston, Christina K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5;

ADAPTIVE IMMUNITY; AIRWAY HYPERRESPONSIVENESS; AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; C57BL MOUSE; CELL PROLIFERATION; CFTR GENE; CHROMOSOME 7; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE LOCUS; GENE MUTATION; IL4RA GENE; ITGAL GENE; LUNG; LUNG FUNCTION; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; STRAIN DIFFERENCE;

ANIMALS; ANTIGENS, CD3; BRONCHIAL HYPERREACTIVITY; CELLS, CULTURED; CHROMOSOMES; CROSSES, GENETIC; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC LOCI; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; SPECIES SPECIFICITY;

EID: 84857495325     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102425     Document Type: Article

References (65)

1. O'Sullivan, B. P., and S. D. Freedman. 2009. Cystic fibrosis. Lancet 373: 1891-1904.
2. Balfour-Lynn, I. M., and J. S. Elborn. 2002. "CF asthma": what is it and what do we do about it? Thorax 57: 742-748.
3. Weinberger, M. 2002. Airways reactivity in patients with CF. Clin. Rev. Allergy Immunol. 23: 77-85. (Pubitemid 34785784)
4. Hubeau, C., M. Lorenzato, J. P. Couetil, D. Hubert, D. Dusser, E. Puchelle, and D. Gaillard. 2001. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin. Exp. Immunol. 124: 69-76. (Pubitemid 32476936)
5. Tan, H. L., N. Regamey, S. Brown, A. Bush, C. M. Lloyd, and J. C. Davies. 2011. The Th17 pathway in cystic fibrosis lung disease. Am. J. Respir. Crit. Care Med. 184: 252-258.
6. Moss, R. B. 2004. Lymphocytes in cystic fibrosis lung disease: a tale of two immunities. Clin. Exp. Immunol. 135: 358-360. (Pubitemid 38297135)
7. Hartl, D., M. Griese, M. Kappler, G. Zissel, D. Reinhardt, C. Rebhan, D. J. Schendel, and S. Krauss-Etschmann. 2006. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117: 204-211. (Pubitemid 43017162)
8. Davidson, D. J., and M. Rolfe. 2001. Mouse models of cystic fibrosis. Trends Genet. 17: S29-S37. (Pubitemid 32918309)
9. Zahm, J. M., D. Gaillard, F. Dupuit, J. Hinnrasky, D. Porteous, J. R. Dorin, and E. Puchelle. 1997. Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. Am. J. Physiol. 272: C853-C859. (Pubitemid 27146699)
10. Thomas, G. R., E. A. Costelloe, D. P. Lunn, K. J. Stacey, S. J. Delaney, R. Passey, E. C. McGlinn, B. J. McMorran, A. Ahadizadeh, C. L. Geczy, et al. 2000. G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages. J. Immunol. 164: 3870-3877. (Pubitemid 30169846)
11. Kent, G., R. Iles, C. E. Bear, L. J. Huan, U. Griesenbach, C. McKerlie, H. Frndova, C. Ackerley, D. Gosselin, D. Radzioch, et al. 1997. Lung disease in mice with cystic fibrosis. J. Clin. Invest. 100: 3060-3069. (Pubitemid 28022844)
12. Sharma, G. D., M. F. Tosi, R. C. Stern, and P. B. Davis. 1995. Progression of pulmonary disease after disappearance of Pseudomonas in cystic fibrosis. Am. J. Respir. Crit. Care Med. 152: 169-173.
13. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150: 448-454. (Pubitemid 24252357)
14. Konstan, M. W., and M. Berger. 1997. Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr. Pulmonol. 24: 137-142, discussion 159-161.
15. Lesprit, E., E. Escudier, G. Roger, V. Prulière, G. Lenoir, P. Reinert, and A. Coste. 2000. Characterization of inflammatory reaction in upper airways of cystic fibrosis patients. Histol. Histopathol. 15: 395-402. (Pubitemid 30218832)
16. Meyer, M., F. Huaux, X. Gavilanes, S. van den BrÛle, P. Lebecque, S. Lo Re, D. Lison, B. Scholte, P. Wallemacq, and T. Leal. 2009. Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 41: 590-602.
17. Legssyer, R., F. Huaux, J. Lebacq, M. Delos, E. Marbaix, P. Lebecque, D. Lison, B. J. Scholte, P. Wallemacq, and T. Leal. 2006. Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. Respir. Res. 7: 134.
18. Hilliard, T. N., J. Zhu, R. Farley, S. Escudero-Garcia, B. J. Wainwright, P. K. Jeffery, U. Griesenbach, A. Bush, J. C. Davies, and E. W. Alton. 2008. Nasal abnormalities in cystic fibrosis mice independent of infection and inflammation. Am. J. Respir. Cell Mol. Biol. 39: 19-25. (Pubitemid 351883954)
19. Haston, C. K., S. Cory, L. Lafontaine, G. Dorion, and M. T. Hallett. 2006. Straindependent pulmonary gene expression profiles of a cystic fibrosis mouse model. Physiol. Genomics 25: 336-345.
20. Allard, J. B., M. E. Poynter, K. A. Marr, L. Cohn, M. Rincon, and L. A. Whittaker. 2006. Aspergillus fumigatus generates an enhanced Th2-biased immune response in mice with defective cystic fibrosis transmembrane conductance regulator. J. Immunol. 177: 5186-5194. (Pubitemid 44527591)
21. Stalvey, M. S., T. M. Brusko, C. Mueller, C. H. Wasserfall, D. A. Schatz, M. A. Atkinson, and T. R. Flotte. 2008. CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes. Cytokine 44: 154-159.
22. Lloyd, C. M., and C. M. Hawrylowicz. 2009. Regulatory T cells in asthma. Immunity 31: 438-449.
23. Gueders, M. M., G. Paulissen, C. Crahay, F. Quesada-Calvo, J. Hacha, C. Van Hove, K. Tournoy, R. Louis, J. M. Foidart, A. Noël, and D. D. Cataldo. 2009. Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm. Res. 58: 845-854.
24. Takeda, K., A. Haczku, J. J. Lee, C. G. Irvin, and E. W. Gelfand. 2001. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 281: L394-L402.
25. Canale-Zambrano, J. C., M. C. Poffenberger, S. M. Cory, D. G. Humes, and C. K. Haston. 2007. Intestinal phenotype of variable-weight cystic fibrosis knockout mice. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G222-G229. (Pubitemid 47105164)
26. Haston, C. K., W. Li, A. Li, M. Lafleur, and J. E. Henderson. 2008. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulatordeficient mice. Am. J. Respir. Crit. Care Med. 177: 309-315. (Pubitemid 351198374)
27. McGovern, T. K., W. S. Powell, B. J. Day, C. W. White, K. Govindaraju, H. Karmouty-Quintana, N. Lavoie, J. J. Tan, and J. G. Martin. 2010. Dimethylthiourea protects against chlorine induced changes in airway function in a murine model of irritant induced asthma. Respir. Res. 11: 138.
28. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890. (Pubitemid 36582406)
29. Ng, P. C., and S. Henikoff. 2003. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31: 3812-3814. (Pubitemid 37442253)
30. Thomas, P. D., M. J. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman, K. Diemer, A. Muruganujan, and A. Narechania. 2003. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 13: 2129-2141. (Pubitemid 37161770)
31. Ramensky, V., P. Bork, and S. Sunyaev. 2002. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30: 3894-3900. (Pubitemid 35012462)
32. Leduc, M. S., R. S. Hageman, R. A. Verdugo, S. W. Tsaih, K. Walsh, G. A. Churchill, and B. Paigen. 2011. Integration of QTL and bioinformatic tools to identify candidate genes for triglycerides in mice. J. Lipid. Res. 52: 1672-1682.
33. Vorraro, F., A. Galvan, W. H. Cabrera, P. S. Carneiro, O. G. Ribeiro, M. De Franco, N. Starobinas, J. R. Jensen, M. Seman, T. A. Dragani, and O. C. Ibañez.2010. Genetic control of IL-1 beta production and inflammatory response by the mouse Irm1 locus. J. Immunol. 185: 1616-1621.
34. Rainbow, D. B., C. Moule, H. I. Fraser, J. Clark, S. K. Howlett, O. Burren, M. Christensen, V. Moody, C. A. Steward, J. P. Mohammed, et al. 2011. Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice. J. Immunol. 187: 325-336.
35. Whitehead, G. S., J. K. Walker, K. G. Berman, W. M. Foster, and D. A. Schwartz. 2003. Allergen-induced airway disease is mouse strain dependent. Am. J. Physiol. Lung Cell. Mol. Physiol. 285: L32-L42. (Pubitemid 36736466)
36. Kearley, J., K. F. Buckland, S. A. Mathie, and C. M. Lloyd. 2009. Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am. J. Respir. Crit. Care Med. 179: 772-781.
37. Takeda, K., N. Miyahara, Y. H. Rha, C. Taube, E. S. Yang, A. Joetham, T. Kodama, A. M. Balhorn, A. Dakhama, C. Duez, et al. 2003. Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am. J. Respir. Crit. Care Med. 168: 783-789. (Pubitemid 37188301)
38. McCusker, C. T., Y. Wang, J. Shan, M. W. Kinyanjui, A. Villeneuve, H. Michael, and E. D. Fixman. 2007. Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J. Immunol. 179: 2556-2564.
39. Bodas, M., T. Min, S. Mazur, and N. Vij. 2011. Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema. J. Immunol. 186: 602-613.
40. Al Alam, D., G. Deslee, C. Tournois, B. Lamkhioued, F. Lebargy, M. Merten, A. Belaaouaj, M. Guenounou, and S. C. Gangloff. 2010. Impaired interleukin-8 chemokine secretion by staphylococcus aureus-activated epithelium and T-cell chemotaxis in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 42: 644-650.
41. Mueller, C., S. A. Braag, A. Keeler, C. Hodges, M. Drumm, and T. R. Flotte. 2011. Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am. J. Respir. Cell Mol. Biol. 44: 922-929.
42. Bubien, J. K. 2001. CFTR may play a role in regulated secretion by lymphocytes: a new hypothesis for the pathophysiology of cystic fibrosis. Pflugers Arch. 443(Suppl 1): S36-S39.
43. Moser, C., S. Kjaergaard, T. Pressler, A. Kharazmi, C. Koch, and N. Høiby. 2000. The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type. APMIS 108: 329-335. (Pubitemid 30456361)
44. Pukhalsky, A. L., G. V. Shmarina, N. I. Kapranov, S. N. Kokarovtseva, D. Pukhalskaya, and N. J. Kashirskaja. 2004. Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease. Mediators Inflamm. 13: 111-117. (Pubitemid 38698140)
45. Zhang, Y., W. J. Lamm, R. K. Albert, E. Y. Chi, W. R. Henderson, Jr., and D. B. Lewis. 1997. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am. J. Respir. Crit. Care Med. 155: 661-669. (Pubitemid 27085817)
46. Kelada, S. N., M. S.Wilson, U. Tavarez, K. Kubalanza, B. Borate, G. Whitehead, S. Maruoka, M. G. Roy, M. Olive, D. E. Carpenter, et al. 2011. Strain-dependent genomic factors affect allergen-induced airway hyper-responsiveness in mice. Am. J. Respir. Cell Mol. Biol. 45: 817-824.
47. -/- mice. Respir. Res. 11: 49.
48. Bonvin, E., P. Le Rouzic, J. F. Bernaudin, C. H. Cottart, C. Vandebrouck, A. Crié, T. Leal, A. Clement, and M. Bonora. 2008. Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice. J. Physiol. 586: 3231-3243. (Pubitemid 351984702)
49. Cottart, C. H., E. Bonvin, C. Rey, D. Wendum, J. F. Bernaudin, S. Dumont, E. Lasnier, D. Debray, A. Clément, C. Housset, and M. Bonora. 2007. Impact of nutrition on phenotype in CFTR-deficient mice. Pediatr. Res. 62: 528-532. (Pubitemid 351338984)
50. Hauber, H. P., F. Lavigne, H. L. Hung, R. C. Levitt, and Q. Hamid. 2010. Effect of Th2 type cytokines on hCLCA1 and mucus expression in cystic fibrosis airways. J. Cyst. Fibros. 9: 277-279.
51. Zosky, G. R., A. N. Larcombe, O. J. White, J. T. Burchell, C. von Garnier, P. G. Holt, D. J. Turner, M. E. Wikstrom, P. D. Sly, and P. A. Stumbles. 2009. Airway hyperresponsiveness is associated with activated CD4+ T cells in the airways. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L373-L379.
52. De Sanctis, G. T., A. Itoh, F. H. Green, S. Qin, T. Kimura, J. K. Grobholz, T. R. Martin, T. Maki, and J. M. Drazen. 1997. T-lymphocytes regulate genetically determined airway hyperresponsiveness in mice. Nat. Med. 3: 460-462. (Pubitemid 27145691)
53. Watanabe, A., P. Rossi, P. M. Renzi, L. J. Xu, R. D. Guttmann, and J. G. Martin. 1995. Adoptive transfer of allergic airway responses with sensitized lymphocytes in BN rats. Am. J. Respir. Crit. Care Med. 152: 64-70.
54. Mehra, D., D. I. Sternberg, Y. Jia, S. Canfield, V. Lemaitre, T. Nkyimbeng, J.Wilder, J. Sonett, and J. D'Armiento. 2010. Altered lymphocyte trafficking and diminished airway reactivity in transgenic mice expressing human MMP-9 in a mouse model of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L189-L196.
55. Yazbek, S. N., D. A. Buchner, J. M. Geisinger, L. C. Burrage, S. H. Spiezio, G. E. Zentner, C. W. Hsieh, P. C. Scacheri, C. M. Croniger, and J. H. Nadeau. 2011. Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis. Genome Res. 21: 1065-1073.
56. Thusberg, J., A. Olatubosun, and M. Vihinen. 2011. Performance of mutation pathogenicity prediction methods on missense variants. Hum. Mutat. 32: 358-368.
57. Kuschei, W. M., J. Leitner, O. Majdic, W. F. Pickl, G. J. Zlabinger, K. Grabmeier-Pfistershammer, and P. Steinberger. 2011. Costimulatory signals potently modulate the T cell inhibitory capacity of the therapeutic CD11a antibody Efalizumab. Clin. Immunol. 139: 199-207.
58. Lee, S. H., J. E. Prince, M. Rais, F. Kheradmand, C. M. Ballantyne, G. Weitz- Schmidt, C. W. Smith, and D. B. Corry. 2008. Developmental control of integrin expression regulates Th2 effector homing. J. Immunol. 180: 4656-4667.
59. Blaeser, F., P. J. Bryce, N. Ho, V. Raman, F. Dedeoglu, D. D. Donaldson, R. S. Geha, H. C. Oettgen, and T. A. Chatila. 2003. Targeted inactivation of the IL-4 receptor alpha chain I4R motif promotes allergic airway inflammation. J. Exp. Med. 198: 1189-1200. (Pubitemid 37323384)
60. Tachdjian, R., C. Mathias, S. Al Khatib, P. J. Bryce, H. S. Kim, F. Blaeser, B. D. O'Connor, D. Rzymkiewicz, A. Chen, M. J. Holtzman, et al. 2009. Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J. Exp. Med. 206: 2191-2204.
61. Shiroiwa, W., K. Tsukamoto, M. Ohtsuji, Q. Lin, A. Ida, S. Kodera, N. Ohtsuji, K. Nakamura, H. Tsurui, K. Kinoshita, et al. 2007. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus. Int. Immunol. 19: 175-183. (Pubitemid 46179012)
62. Choi, P., D. Xanthaki, S. J. Rose, M. Haywood, H. Reiser, and B. J. Morley. 2005. Linkage analysis of the genetic determinants of T-cell IL-4 secretion, and identification of Flj20274 as a putative candidate gene. Genes Immun. 6: 290-297. (Pubitemid 40903401)
63. Bix, M., Z. E. Wang, B. Thiel, N. J. Schork, and R. M. Locksley. 1998. Genetic regulation of commitment to interleukin 4 production by a CD4(+) T cellintrinsic mechanism. J. Exp. Med. 188: 2289-2299. (Pubitemid 29028501)
64. Nguyen, H., and N. P. Weng. 2010. IL-21 preferentially enhances IL-15- mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span. J. Leukoc. Biol. 87: 43-49.
65. Fröhlich, A., B. J. Marsland, I. Sonderegger, M. Kurrer, M. R. Hodge, N. L. Harris, and M. Kopf. 2007. IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. Blood 109: 2023-2031.